S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
NASDAQ:GEHC

GE HealthCare Technologies (GEHC) Stock Price, News & Analysis

$92.72
+1.44 (+1.58%)
(As of 03/1/2024 ET)
Today's Range
$90.58
$93.06
50-Day Range
$71.55
$93.02
52-Week Range
$62.35
$93.96
Volume
2.70 million shs
Average Volume
4.40 million shs
Market Capitalization
$42.22 billion
P/E Ratio
30.70
Dividend Yield
0.13%
Price Target
$88.83

GE HealthCare Technologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.62 Rating Score
Upside/​Downside
4.2% Downside
$88.83 Price Target
Short Interest
Healthy
3.70% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.04mentions of GE HealthCare Technologies in the last 14 days
Based on 11 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.56%
From $4.30 to $4.84 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.29 out of 5 stars

Medical Sector

583rd out of 950 stocks

X - Ray Apparatus & Tubes Industry

4th out of 6 stocks


GEHC stock logo

About GE HealthCare Technologies Stock (NASDAQ:GEHC)

GE HealthCare Technologies Inc. is a leading player in the medical industry, specializing in developing and manufacturing advanced healthcare technologies. With a strong commitment to improving patient outcomes and advancing medical science, the company has established itself as a trusted provider of innovative solutions for healthcare professionals worldwide.

The mission of GE HealthCare Technologies Inc. is to revolutionize healthcare through cutting-edge technology and collaboration. By leveraging its expertise in medical imaging, diagnostics, and biopharmaceutical manufacturing, the company aims to enable healthcare providers to deliver more precise diagnoses, personalized treatment options, and better patient care.

Headquartered in Chicago, Illinois, GE HealthCare Technologies Inc. has a global presence, with operations spanning multiple countries. Its products and services cater to various medical specialties, including radiology, cardiology, oncology, neurology, and more. The company's comprehensive portfolio encompasses medical imaging systems, diagnostic tools, pharmaceutical manufacturing equipment, and digital health solutions.

GE HealthCare Technologies Inc. serves a diverse customer base, including hospitals, clinics, research institutions, and pharmaceutical companies. The company has established strategic partnerships with leading healthcare providers and organizations to drive collaborative innovation and address pressing healthcare challenges.

GE HealthCare Technologies Inc. is led by a dynamic management team with extensive experience in the healthcare industry. The company's Chief Executive Officer (CEO) is Peter Arduini, a seasoned executive known for his strategic vision and operational expertise. Under his leadership, GE HealthCare Technologies Inc. has consistently pursued innovation and growth opportunities.

Jan Makela serves as the CEO of Imaging, overseeing the company's imaging solutions portfolio. With a strong background in medical technology and a focus on customer-centric innovation, Makela has played a crucial role in developing cutting-edge imaging technologies.

GE HealthCare Technologies Inc. has demonstrated strong financial performance in recent years, with consistent revenue growth and solid profit margins. The company's annual sales reached an impressive $18.34 billion in 2022, reflecting its position as a key player in the medical technology industry.

GE HealthCare Technologies Inc. has maintained a healthy financial position, with a favorable price-to-earnings ratio, indicating investor confidence in the company's future earnings potential. The forward-looking price-to-earnings-growth ratio of 3 suggests that the company is well-positioned for sustainable long-term growth.

The company's profitability is further highlighted by its impressive price-to-sales ratio, which indicates that investors are willing to pay a premium for GE HealthCare Technologies Inc.'s products and services. The company's strong cash flow position demonstrates the company's ability to generate substantial cash and reinvest in research and development initiatives.

GE HealthCare Technologies Inc. operates within the broader medical technology industry, encompassing various sub-sectors such as medical imaging, diagnostics, and biopharmaceutical manufacturing. This industry is characterized by rapid technological advancements, increasing demand for innovative solutions, and a growing emphasis on personalized patient care.

Competitors in the medical technology sector include established companies such as Siemens Healthineers, Philips Healthcare, Medtronic, and smaller niche players. GE Healthcare Technologies Inc. distinguishes itself through its diverse product portfolio, global presence, and commitment to continuous innovation.

The company's competitive advantage lies in its strong research and development capabilities, technological expertise, and strategic partnerships. These factors enable GE HealthCare Technologies Inc. to introduce cutting-edge solutions, improve patient outcomes and maintain a strong market position.

GE HealthCare Technologies Inc. is well-positioned to seize growth opportunities in the medical technology industry. The company can capitalize on several factors, including advancements in artificial intelligence and machine learning, increased demand for digital health solutions, and the rising prevalence of chronic diseases.

By leveraging its technological expertise, GE HealthCare can continue to develop innovative products and services that address these industry trends. Additionally, expanding into emerging markets, forging strategic partnerships, and pursuing acquisitions can provide avenues for further growth and market expansion.

While GE HealthCare Technologies Inc. has demonstrated resilience and growth potential, it faces risks and challenges inherent to the medical technology industry. Regulatory changes, evolving reimbursement models, and intense competition can impact the company's operations and profitability.

To mitigate these risks, GE HealthCare Technologies Inc. employs robust risk management strategies, including continuous monitoring of regulatory developments, diversification of product offerings, and proactive engagement with healthcare stakeholders. The company's strong research and development capabilities and focus on innovation allow it to adapt to evolving market dynamics and stay ahead of the competition.

GEHC Stock Price History

GEHC Stock News Headlines

GEHC Oct 2024 70.000 put
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
GE HealthCare Q4 Earnings: Innovation Unleashed
GE HealthCare Q4 Earnings: Growth Lagging The Market
See More Headlines
Receive GEHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/15 Dividend
1/12/2024
Last Earnings
2/06/2024
Dividend Payable
2/15/2024
Today
3/02/2024
Next Earnings (Estimated)
4/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
X - ray apparatus & tubes
Sub-Industry
N/A
Current Symbol
NASDAQ:GEHC
Fax
N/A
Employees
51,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$88.83
High Stock Price Target
$100.00
Low Stock Price Target
$80.00
Potential Upside/Downside
-4.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.62
Research Coverage
13 Analysts

Profitability

Net Income
$1.57 billion
Pretax Margin
12.07%

Debt

Sales & Book Value

Annual Sales
$19.55 billion
Cash Flow
$5.37 per share
Book Value
$15.69 per share

Miscellaneous

Free Float
454,401,000
Market Cap
$42.22 billion
Optionable
Optionable
Beta
0.95
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Peter J. Arduini (Age 59)
    President, CEO & Director
    Comp: $2.26M
  • Mr. Frank R. Jimenez Esq. (Age 59)
    General Counsel & Corporate Secretary
    Comp: $1.85M
  • Ms. Betty D. Larson (Age 48)
    Chief People Officer
    Comp: $1.78M
  • Mr. Jan Makela (Age 55)
    Chief Executive Officer of Imaging
    Comp: $955.06k
  • Mr. James K. Saccaro (Age 51)
    VP & CFO
  • Mr. George Andrew Newcomb (Age 57)
    Controller & Chief Accounting Officer
  • Dr. Taha Kass-Hout M.D. (Age 51)
    M.S., Chief Science & Technology Officer
  • Mr. Thomas J. Westrick (Age 55)
    Chief Executive Officer of Patient Care Solutions
  • Mr. Kevin M. O'Neill (Age 55)
    Chief Executive Officer of Pharmaceutical Diagnostics
  • Mr. Roland Rott (Age 52)
    CEO of Ultrasound

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of GE HealthCare Technologies was last updated on Saturday, March 2, 2024 at 5:05 PM.

Pros

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

  • GE HealthCare Technologies Inc. has shown consistent revenue growth, with a 5.3% increase in revenue compared to the same quarter last year.
  • The company reported a strong quarterly earnings result, beating analysts' consensus estimates by $0.11 per share, indicating a positive financial performance.
  • Analysts have given GE HealthCare Technologies Inc. a "Moderate Buy" rating with an average target price of $88.83, suggesting potential upside.
  • GE HealthCare Technologies Inc. has a low dividend payout ratio of 3.97%, indicating the company has room for dividend growth or reinvestment in the business.
  • The stock price of GE HealthCare Technologies Inc. has been trading at a 12-month high of $87.83, showing positive investor sentiment.

Cons

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

  • Despite positive financial performance, GE HealthCare Technologies Inc. operates in a competitive market with other healthcare technology companies, which may pose challenges.
  • The stock price of GE HealthCare Technologies Inc. has a PE ratio of 28.48, which may indicate the stock is currently overvalued.
  • While the company has a strong return on equity of 25.58%, investors should consider the impact of any potential changes in market conditions on this metric.
  • GE HealthCare Technologies Inc. operates in multiple segments, which could lead to operational complexities and risks associated with managing diverse product lines.
  • Investors should closely monitor any regulatory changes or industry disruptions that could affect GE HealthCare Technologies Inc.'s business operations and financial performance.














GEHC Stock Analysis - Frequently Asked Questions

Should I buy or sell GE HealthCare Technologies stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GEHC shares.
View GEHC analyst ratings
or view top-rated stocks.

What is GE HealthCare Technologies' stock price target for 2024?

13 Wall Street research analysts have issued 1-year price objectives for GE HealthCare Technologies' stock. Their GEHC share price targets range from $80.00 to $100.00. On average, they anticipate the company's share price to reach $88.83 in the next twelve months. This suggests that the stock has a possible downside of 4.2%.
View analysts price targets for GEHC
or view top-rated stocks among Wall Street analysts.

How have GEHC shares performed in 2024?

GE HealthCare Technologies' stock was trading at $77.32 at the beginning of 2024. Since then, GEHC stock has increased by 19.9% and is now trading at $92.72.
View the best growth stocks for 2024 here
.

When is GE HealthCare Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.
View our GEHC earnings forecast
.

How were GE HealthCare Technologies' earnings last quarter?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) issued its quarterly earnings results on Tuesday, February, 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.07 by $0.11. The business had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a trailing twelve-month return on equity of 25.58%. The business's quarterly revenue was up 5.3% on a year-over-year basis. During the same period last year, the firm earned $1.31 earnings per share.

How often does GE HealthCare Technologies pay dividends? What is the dividend yield for GE HealthCare Technologies?

GE HealthCare Technologies declared a quarterly dividend on Friday, December 8th. Shareholders of record on Tuesday, January 16th will be paid a dividend of $0.03 per share on Thursday, February 15th. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. The ex-dividend date of this dividend is Friday, January 12th.
Read our dividend analysis for GEHC
.

Is GE HealthCare Technologies a good dividend stock?

GE HealthCare Technologies (NASDAQ:GEHC) pays an annual dividend of $0.12 per share and currently has a dividend yield of 0.13%. The dividend payout ratio is 3.97%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, GEHC will have a dividend payout ratio of 2.48% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for GEHC.

What guidance has GE HealthCare Technologies issued on next quarter's earnings?

GE HealthCare Technologies issued an update on its FY24 earnings guidance on Tuesday, February, 6th. The company provided EPS guidance of $4.20-$4.35 for the period, compared to the consensus earnings per share estimate of $4.24.

Who are GE HealthCare Technologies' major shareholders?

GE HealthCare Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include Capital Research Global Investors (11.28%), Vanguard Group Inc. (9.75%), Dodge & Cox (3.73%), Price T Rowe Associates Inc. MD (2.66%), Hotchkis & Wiley Capital Management LLC (1.21%) and Newport Trust Company LLC (0.96%). Insiders that own company stock include H Lawrence Culp Jr, Jan Makela, Kevin Michael O'neill and Roland Rott.
View institutional ownership trends
.

How do I buy shares of GE HealthCare Technologies?

Shares of GEHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GEHC) was last updated on 3/2/2024 by MarketBeat.com Staff